Trial Profile
The effects of intrathecal neostigmine added to bupivacaine on postoperative analgesic requirement in Patients undergoing lower limb orthopaedic surgery
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 16 Jul 2019
Price :
$35
*
At a glance
- Drugs Neostigmine (Primary) ; Bupivacaine
- Indications Postoperative pain
- Focus Therapeutic Use
- 20 Nov 2018 Status changed from recruiting to completed.
- 26 Aug 2016 Planned End Date changed from 23 Oct 2013 to NULL.
- 17 Sep 2013 New trial record